Capromorelin

Shares of Aratana Therapeutics Inc (NASDAQ: PETX) were surging higher by more than 17 percent Monday after the company announced positive results from its pivotal field effectiveness study of capromorelin (AT-002), the company's innovative therapeutic for appetite stimulation in dogs. Aratana...